Intranasal Xylitol for the Treatment of COVID-19 in the Outpatient Setting: A Pilot Study.
Soler E, de Mendoza A, Cuello VI, Silva-Vetri MG, Núñez ZH, Ortega RG, Rizvi SA, Sanchez-Gonzalez M, Ferrer G.
Soler E, et al.
Cureus. 2022 Jul 23;14(7):e27182. doi: 10.7759/cureus.27182. eCollection 2022 Jul.
Cureus. 2022.
PMID: 36039203
Free PMC article.
Xylitol has been shown to display virucidal effects against SARS-CoV-2. This study aimed to examine the efficacy of xylitol as an adjunct treatment for COVID-19 in an outpatient setting. ...There were no statistically significant interactions found for VAS (P=0.124) …
Xylitol has been shown to display virucidal effects against SARS-CoV-2. This study aimed to examine the efficacy of xylitol as …